$NKE

Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Marke

Nike Inc (NKE) reported Q1 revenue of $11.21B, missing estimates of $11.33B, but beat EPS estimates. Shares fell 9.5% in pre-market trading. Other stocks like Roze AI (RZAI) and Mangoceuticals (MGRX) also declined.

Original reporting
Published Oct 2, 2026, 12:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 12:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NKE
Bearish
high confidence
Mentioned
$NKE · $MGRX
Relevance
9/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$NKEBearishHigh
01

Why it matters

The revenue miss triggered a 9.5% pre‑market decline, indicating immediate market reaction.

02

Market read

Nike's earnings miss is a high‑impact event for the consumer sector and may influence related stocks.

03

What to watch

Nike's upcoming product launches and international demand could offset short‑term revenue concerns.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Nike's Q1 earnings were released ahead of the broader consumer‑discretionary earnings season.

Company-level read

Ticker impact

$NKEBearishHigh confidence
Context

Nike reported Q1 revenue of $11.21B, missing estimates, and shares fell 9.5% in pre‑market trading.

Expected impact

likely further downside as investors price in the revenue shortfall

Evidence & confidence

The miss of $120M versus consensus is material for a large‑cap and triggered a double‑digit pre‑market drop.

Market effects

Footwear and apparel sector may see broader pressure as peers are compared to Nike's miss.

U.S. equity markets could open lower on consumer‑discretionary weakness.

Limited to markets tracking U.S. consumer stocks.

Counterpoint

Some investors may view the EPS beat as a buying opportunity if revenue guidance improves.

Key entities

  • Nike Inc.

    Global athletic apparel and footwear manufacturer.

Related articles

$NKEMedAI 8/10

Nike Reports Q1 Revenue Of $11.2 Billion As Pace Program Targets $2.5 Billion In Savings

NIKE reported Q1 2027 revenue of $11.2 billion, down 4%, with gross margin expanding to 42.8%. Net income fell 2% to $700 million. The company launched 'Pace,' a transformation program targeting $2.5 billion in savings by 2031, with $1 billion in pretax charges expected. NIKE expects fiscal 2027 revenue to decline by a high-single-digit percentage and adjusted EPS between $1.15 and $1.35.

$NKEHighAI 8/10

Nike Stock Falls 9% as Soft Revenue Outlook and Restructuring Plan Overshadow Earnings Beat

Nike (NKE) shares fell 9% in extended trading after reporting mixed Q1 results. EPS beat estimates at 48 cents, but revenue declined 4% to $11.21B. China revenue dropped 26%, while North America performed well. Nike expects high-single-digit revenue decline in fiscal 2027 and announced a restructuring plan called Pace, aiming for $2.5B in savings by fiscal 2031. CEO Elliott Hill cited weakness in Sportswear and China as concerns.

$NKEMed

Bernstein cuts Nike stock price target on worsened outlook

Bernstein cut Nike's (NKE) price target to $45 from $68, citing weaker-than-expected Q1 results and fiscal 2027 guidance. NKE shares are down 43% YTD, trading near 52-week lows. Multiple analysts revised earnings and price targets downward, citing revenue challenges and a slowdown in sportswear demand. Nike plans to provide a five-year strategy at an investor day in November.

$NKEHighAI 8/10

NIKE Q1 Earnings Beat on Margin Gain, Stock Falls on Revenue Miss

NIKE reported Q1 2027 earnings of $0.48 per share, beating estimates by 11.6%, but revenues fell 4.3% to $11.2B, missing expectations. Shares dropped over 8% in after-hours trading. Gross margin expanded 60 bps to 42.8%, supported by cost savings. The company expects fiscal 2027 revenues to decline in the high-single-digit range and introduced a cost-saving program, Pace, aiming for $2.5B in savings by 2031.